Results of a recent study linking low LDL cholesterol to Parkinson’s provide the strongest evidence to date that it could be real, because statins work by reducing LDL cholesterol. The study by researchers at University of North Carolina showed that patients with low levels of LDL cholesterol are more than three and a half times more likely to develop Parkinson’s disease than those with higher LDL levels.
Cardiovascular disease is the most common cause of death in the United States. Although some risk factors, such as age and heredity, cannot be controlled, many factors, including smoking, cholesterol, blood pressure, obesity and inactivity can be modified, thus, lowering the risk. This lifestyle concern is thoroughly explored in the headline article of the debut issue of the new American Journal of Lifestyle Medicine (AJLM) published by SAGE.
Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. The findings are in the January 11 issue of the New England Journal of Medicine (NEJM). In this study, patients with homozygous familial hypercholesterolemia (FH), a high-risk condition refractory to conventional therapy, had a remarkable 51 percent reduction in low-density lipoprotein (LDL) or “bad cholesterol” levels.
JHUSON Associate Professor Miyong T. Kim, PhD, RN and colleagues have found there is a steeply increasing incidence of coronary heart disease (CHD) in developing countries undergoing rapid westernization, including South Korea.
In a community-based study led by Allen?nurse researchers explored the beneficial effects of soy. The array of results garnered from the multi-year study focused on cholesterol reduction, metabolic syndrome, and recruitment for clinical trials.
The phrase “breakfast is the most important meal of the day” has taken on new meaning for teenagers. A new study suggests that as teens enter adulthood, they are more likely to skip breakfast and increase their fast food consumption, and that both behaviors lead to an increased risk of weight gain. Researchers at the Weight Control and Diabetes Research Center at the Miriam Hospital and Brown Medical School conducted the study.
Nutrition 21, Inc., today announced the results of a recent placebo controlled, double-blind, randomized, single center study that demonstrated that Diachrome, a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
Results from the NHLBI Growth and Health Study of more than 2,300 girls suggest that girls as young as age 9 who are overweight are at increased risk for short-term and long-term problems that increase the chances of developing cardiovascular disease. Those who were overweight were more likely to have elevated blood pressure and cholesterol levels compared to girls who were not overweight. The study also provides insight into differences between African-American and Caucasian girls.
Australian researchers say that a genotype that heightens the risk for Alzheimer’s disease does not contribute to cognitive change during most of adulthood. The largest study of its kind has found that carriers and noncarriers show the same type and extent of normal age-related cognitive declines, decades before carriers start to more often develop symptoms of dementia. The findings suggest that the higher-risk genotype acts only in later years to layer disease on top of normal aging.
Most of us think of chromium as the shiny metal in the bumpers of cars. Chrome bumpers are long gone, but the metal plays a crucial role in human health, reports the January 2007 issue of Harvard Men?s Health Watch.